European Archives - Page 666 of 1109 - European Medical Journal

Does pharma need more 'social' leaders?

Pharmaceutical companies have embraced the corporate social media account, but many lack the personal touch of a profile run by their leader. The opportunity to connect with employees and patients alike is unbounded; the time to log on is now.

Heavy Wildfire Smoke Exposure Associated with Risk of Out-Of-Hospital Cardiac Arrest

Heavy Wildfire Smoke Exposure Associated with Risk of Out-Of-Hospital Cardiac Arrest

WILDFIRE smoke has been linked to a heightened risk of out-of-hospital cardiac arrests, in some cases by as much as 70%…

New Risk Stratification Model Developed for Patients Following Percutaneous Coronary Intervention

New Risk Stratification Model Developed for Patients Following Percutaneous Coronary Intervention

ACCURATE outcomes have been better predicted in ST-segment elevation myocardial infarction (STEMI) patients having undergone…

Lupus Panniculitis in Association with Anti-Phospholipid Antibody Syndrome on a Background of Systemic Lupus Erythematosus: A Case Report and Literature Review

Lupus panniculitis, also known as lupus profundus,1 is characterised by chronic and recurrent inflammatory lesions of subcutaneous tissue…

Innovation: Lessons Learned From a Surgical Neoteric's Perspective

In this webinar, Professor Jonathan Sackier shares his insights on innovation, looking at this from a surgeon’s perspective, and outlines the crucial differences between innovation and invention.

ICDS Interview with Dr Miklosh Bala

Dr Jonathan Sackier sat down with Dr Miklosh Bala to discuss, among other things, trauma surgery in the Israeli capital of Jerusalem.

The Illusion of Remission

Dr Raine described corticosteroids as the first IBD drugs to undergo clinical trials. A seminal study, one of the first to introduce the concept…

EMJ Gastroenterology 9 [Suppl 3] 2020

Taking place at the 15th congress of the European Crohn’s and Colitis Organisation (ECCO) in the beautiful Austrian capital of Vienna, the AbbVie…

An interview with Prof Janneke van der Woude at UEG Week Barcelona 2019

We spoke to Prof Janneke van der Woude (UEG General Gastroenterology Representative) at UEG Week 2019…

Will α-Ketoglutarate Supplementation Pave a New Way for Colorectal Cancer Treatment?

Will α-Ketoglutarate Supplementation Pave a New Way for Colorectal Cancer Treatment?

COLORECTAL CANCER predominantly stems from a genetic mutation of APC. In general, a major proportion of people with the mutation…